Setting a Course for Preventing Hepatitis e in Low and Lower-Middle-Income Countries: A Systematic Review of Burden and Risk Factors

Aybüke Koyuncu, Daniel Mapemba, Iza Ciglenecki, Emily S. Gurley, Andrew S. Azman

Research output: Contribution to journalReview articlepeer-review


Background: Hepatitis E virus (HEV) is responsible for outbreaks of acute jaundice in Africa and Asia, many of which occur among displaced people or in crisis settings. Although an efficacious vaccine for HEV has been developed, we lack key epidemiologic data needed to understand how best to use the vaccine for hepatitis E control in endemic countries. Methods: We conducted a systematic review of articles published on hepatitis E in low-income and lower-middle-income countries in Africa and Asia. We searched PubMed, Scopus, and Embase databases to identify articles with data on anti-HEV immunoglobulin (Ig)G seroprevalence, outbreaks of HEV, or risk factors for HEV infection, disease, or death, and all relevant data were extracted. Using these data we describe the evidence around temporal and geographical distribution of HEV transmission and burden. We estimated pooled age-specific seroprevalence and assessed the consistency in risk factor estimates. Results: We extracted data from 148 studies. Studies assessing anti-HEV IgG antibodies used 18 different commercial assays. Most cases of hepatitis E during outbreaks were not confirmed. Risk factor data suggested an increased likelihood of current or recent HEV infection and disease associated with fecal-oral transmission of HEV, as well as exposures to blood and animals. Conclusions: Heterogeneity in diagnostic assays used and exposure and outcome assessment methods hinder public health efforts to quantify burden of disease and evaluate interventions over time and space. Prevention tools such as vaccines are available, but they require a unified global strategy for hepatitis E control to justify widespread use.

Original languageEnglish (US)
Article numberofab178
JournalOpen Forum Infectious Diseases
Issue number6
StatePublished - Jun 1 2021


  • hepatitis E
  • hepatitis E virus (HEV)
  • outbreaks
  • risk factors
  • seroprevalence

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology


Dive into the research topics of 'Setting a Course for Preventing Hepatitis e in Low and Lower-Middle-Income Countries: A Systematic Review of Burden and Risk Factors'. Together they form a unique fingerprint.

Cite this